SI2563763T1 - Farmacevtski sestavki, ki obsegajo N-(4-(2-amino-3-kloropiridin-4-iloksi)-3-fluorofenil)-4-etoksi-L-(4- fluorofenil)-2-okso-1,2-dihidropiridin-3-karboksamid - Google Patents
Farmacevtski sestavki, ki obsegajo N-(4-(2-amino-3-kloropiridin-4-iloksi)-3-fluorofenil)-4-etoksi-L-(4- fluorofenil)-2-okso-1,2-dihidropiridin-3-karboksamidInfo
- Publication number
- SI2563763T1 SI2563763T1 SI201130405T SI201130405T SI2563763T1 SI 2563763 T1 SI2563763 T1 SI 2563763T1 SI 201130405 T SI201130405 T SI 201130405T SI 201130405 T SI201130405 T SI 201130405T SI 2563763 T1 SI2563763 T1 SI 2563763T1
- Authority
- SI
- Slovenia
- Prior art keywords
- fluorophenyl
- chloropyridin
- dihydropyridine
- yloxy
- carboxamide
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Pyridine Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32971010P | 2010-04-30 | 2010-04-30 | |
| EP11717917.6A EP2563763B1 (en) | 2010-04-30 | 2011-04-29 | Pharmaceutical compositions comprising n-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-l-(4-fluorophenyl)-2-oxo- 1,2-dihydropyridine-3 -carboxamide |
| PCT/US2011/034417 WO2011137274A1 (en) | 2010-04-30 | 2011-04-29 | Pharmaceutical compositions comprising n-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-l-(4-fluorophenyl)-2-oxo- 1,2-dihydropyridine-3 -carboxamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI2563763T1 true SI2563763T1 (sl) | 2015-03-31 |
Family
ID=44209564
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI201130405T SI2563763T1 (sl) | 2010-04-30 | 2011-04-29 | Farmacevtski sestavki, ki obsegajo N-(4-(2-amino-3-kloropiridin-4-iloksi)-3-fluorofenil)-4-etoksi-L-(4- fluorofenil)-2-okso-1,2-dihidropiridin-3-karboksamid |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US8911785B2 (enExample) |
| EP (1) | EP2563763B1 (enExample) |
| JP (1) | JP5820874B2 (enExample) |
| KR (1) | KR101897302B1 (enExample) |
| CN (1) | CN102971296B (enExample) |
| DK (1) | DK2563763T3 (enExample) |
| ES (1) | ES2533075T3 (enExample) |
| HR (1) | HRP20150105T1 (enExample) |
| MY (1) | MY183769A (enExample) |
| PH (1) | PH12012502019A1 (enExample) |
| PL (1) | PL2563763T3 (enExample) |
| PT (1) | PT2563763E (enExample) |
| RS (1) | RS53790B1 (enExample) |
| SG (1) | SG184891A1 (enExample) |
| SI (1) | SI2563763T1 (enExample) |
| SM (1) | SMT201500069B (enExample) |
| WO (1) | WO2011137274A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106635949B (zh) | 2011-12-22 | 2020-05-19 | 生命技术公司 | 细胞培养基和方法 |
| WO2016126012A1 (en) * | 2015-02-05 | 2016-08-11 | Boryung Pharmaceutical Co., Ltd | Tablet and method of preparing the same |
| KR101545268B1 (ko) | 2015-02-05 | 2015-08-20 | 보령제약 주식회사 | 정제 및 이의 제조방법 |
| EP3911320A4 (en) * | 2019-01-15 | 2022-11-30 | The Translational Genomics Research Institute | PHOSPHONATE CONJUGATES AND THEIR USES |
| US20230257364A1 (en) * | 2022-02-16 | 2023-08-17 | Cmg Pharmaceutical Co., Ltd. | Pyridazinone-based compounds as axl, c-met, and mer inhibitors and methods of use thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6214344B1 (en) | 1995-06-02 | 2001-04-10 | Genetech, Inc. | Hepatocyte growth factor receptor antagonists and uses thereof |
| CA2266448A1 (en) * | 1996-09-24 | 1998-04-02 | Eli Lilly And Company | Coated particle formulation |
| US7459562B2 (en) | 2004-04-23 | 2008-12-02 | Bristol-Myers Squibb Company | Monocyclic heterocycles as kinase inhibitors |
| US20100016378A1 (en) * | 2005-04-28 | 2010-01-21 | Toshio Suzuki | Method of preventing dihydropyridine compound from degradation |
| TR200504775A1 (tr) | 2005-11-30 | 2007-10-22 | Esen Beki̇r | Kendinden metal takviyeli pvc pencere ve kapı profilleri |
| US8865722B2 (en) * | 2006-01-05 | 2014-10-21 | Teva Pharmaceutical Industries Ltd. | Wet formulations of aripiprazole |
| MX2009004699A (es) * | 2006-11-08 | 2009-05-15 | Bristol Myers Squibb Co | Compuestos de piridinona. |
| US20080260837A1 (en) * | 2007-04-20 | 2008-10-23 | Qpharma, L.L.C. | Physically stable aqueous suspensions of active pharmaceuticals |
| US8263652B2 (en) * | 2007-10-31 | 2012-09-11 | Sk Biopharmaceuticals Co., Ltd. | Stabilized pediatric suspension of carisbamate |
| EP2235001B1 (en) | 2008-01-23 | 2014-12-24 | Bristol-Myers Squibb Company | Process for preparing pyridinone compounds |
-
2011
- 2011-04-29 RS RS20150055A patent/RS53790B1/sr unknown
- 2011-04-29 CN CN201180032341.1A patent/CN102971296B/zh active Active
- 2011-04-29 HR HRP20150105AT patent/HRP20150105T1/hr unknown
- 2011-04-29 SG SG2012076865A patent/SG184891A1/en unknown
- 2011-04-29 JP JP2013508267A patent/JP5820874B2/ja active Active
- 2011-04-29 EP EP11717917.6A patent/EP2563763B1/en active Active
- 2011-04-29 KR KR1020127031220A patent/KR101897302B1/ko active Active
- 2011-04-29 WO PCT/US2011/034417 patent/WO2011137274A1/en not_active Ceased
- 2011-04-29 MY MYPI2012004708A patent/MY183769A/en unknown
- 2011-04-29 SI SI201130405T patent/SI2563763T1/sl unknown
- 2011-04-29 US US13/643,561 patent/US8911785B2/en active Active
- 2011-04-29 PH PH1/2012/502019A patent/PH12012502019A1/en unknown
- 2011-04-29 PT PT11717917T patent/PT2563763E/pt unknown
- 2011-04-29 PL PL11717917T patent/PL2563763T3/pl unknown
- 2011-04-29 ES ES11717917.6T patent/ES2533075T3/es active Active
- 2011-04-29 DK DK11717917.6T patent/DK2563763T3/en active
-
2014
- 2014-09-15 US US14/486,139 patent/US9233948B2/en active Active
-
2015
- 2015-03-18 SM SM201500069T patent/SMT201500069B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP5820874B2 (ja) | 2015-11-24 |
| SMT201500069B (it) | 2015-05-05 |
| EP2563763B1 (en) | 2014-12-31 |
| MY183769A (en) | 2021-03-12 |
| CN102971296A (zh) | 2013-03-13 |
| PL2563763T3 (pl) | 2015-06-30 |
| US8911785B2 (en) | 2014-12-16 |
| EP2563763A1 (en) | 2013-03-06 |
| WO2011137274A1 (en) | 2011-11-03 |
| US20130039989A1 (en) | 2013-02-14 |
| CN102971296B (zh) | 2015-11-25 |
| SG184891A1 (en) | 2012-11-29 |
| KR101897302B1 (ko) | 2018-09-11 |
| HRP20150105T1 (hr) | 2015-03-13 |
| ES2533075T3 (es) | 2015-04-07 |
| PT2563763E (pt) | 2015-03-31 |
| KR20130100237A (ko) | 2013-09-10 |
| JP2013525455A (ja) | 2013-06-20 |
| RS53790B1 (sr) | 2015-06-30 |
| PH12012502019A1 (en) | 2017-08-18 |
| US9233948B2 (en) | 2016-01-12 |
| DK2563763T3 (en) | 2015-04-07 |
| AU2011245269A1 (en) | 2012-12-20 |
| HK1179260A1 (en) | 2013-09-27 |
| US20150065719A1 (en) | 2015-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL222878A (en) | N - ((2-oxo-2,1-dihydropyridine-3-ram) methyl) -1h-indole-4-carboxamide and pharmaceuticals containing them | |
| EP2566859A4 (en) | PICOLINAMIDE AND PYRIMIDINE-4-CARBOXAMIDE COMPOUNDS, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION THEREWITH | |
| TWI560183B (en) | Compounds and compositions for inhibiting the activity of abl1, abl2 and bcr-abl1 | |
| ZA201407341B (en) | Substituted hetero-bicyclic compounds, compositions and medicinal applications thereof | |
| IL233154A (en) | Compounds, pharmaceuticals containing them and their uses | |
| ZA201404733B (en) | Novel benzopyran compounds, compositions and uses thereof | |
| DK3284467T3 (da) | Nikotinholdige farmaceutiske sammensætninger | |
| IL220863A (en) | Oxazole derivatives of kinase inhibitors, medicinal preparations containing them and their uses | |
| IL233863A (en) | Pyridine derivatives, preparations containing them and their uses | |
| IL232035A (en) | These heterocyclic compounds, these compounds as a medicine and a pharmaceutical composition containing them | |
| BR112015002738A2 (pt) | composto , e , composição farmacêutica | |
| IL232914A0 (en) | New Azetidine histories, pharmaceutical preparations and their uses | |
| EP2827857A4 (en) | SPIROCYCLIC DIHYDRO-THIAZINE AND INHIBITORS OF BACE DIHYDRO-OXAZINE AND COMPOSITIONS AND USES THEREOF | |
| HUE037747T2 (hu) | Nanostrukturált aprepirant készítmények, eljárások azok elõállítására és az azokat tartalmazó gyógyászati készítmények | |
| BR112015003259A2 (pt) | composto, composição farmacêutica, e, composição de vacina. | |
| IL232917A0 (en) | History of 5-(3-aminophenyl)-5-alkyl-6,5-dihydro-2h[4,1]oxazin-3-amine | |
| IL238060B (en) | 2-aminopyridine derivatives, their preparation and pharmaceutical compositions containing them | |
| IT1397694B1 (it) | Puntale per attacchi da sci-alpinismo. | |
| AP2012006232A0 (en) | New association between 4-ä3-ÄCIS-hexahydrocyclopentaÄcÜpyrrol-2(1H)-YLÜpropoxyübenzamide and an Acetylcholinesterase inhibitor, and pharmaceutical compositions containing it. | |
| IL237674A (en) | Herbicides containing aminopyridide and triclovir | |
| EP2668186A1 (en) | Pharmaceutical composition comprising pyridone derivatives | |
| IL230484A (en) | "6- (n- (7-Chloro-1-Hydroxy-1, 3-Dihydrobenzo [c] [1,2] Oxaborol-5-Yl) - Methylbenzoforan-3 - Carbamamide and a Pharmaceutical Preparation | |
| SMT201500069B (it) | Composizioni farmaceutiche comprendenti n-(4-(2-ammino-3-cloropiridin-4-ilossi)-3-fluorofenil)-4-etossi-l-(4-fluorofenil)-2-osso-1,2-diidropiridin-3-carbossammide | |
| IL237542A0 (en) | Amphiphilic compounds, their preparations and uses | |
| BR112014032501A2 (pt) | composto, e, composição farmacêutica. |